APA

Bogaerts J., Cardoso F., Buyse M., Braga S., Loi S., Harrison J. A., Bines J., Mook S., Decker N., Ravdin P., Therasse P., Rutgers E., van 't Veer L. J. & Piccart M. (20061024). Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. : Nature clinical practice. Oncology.

Chicago

Bogaerts Jan, Cardoso Fatima, Buyse Marc, Braga Sofia, Loi Sherene, Harrison Jillian A, Bines Jacques, Mook Stella, Decker Nuria, Ravdin Peter, Therasse Patrick, Rutgers Emiel, van 't Veer Laura J and Piccart Martine. 20061024. Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. : Nature clinical practice. Oncology.

Harvard

Bogaerts J., Cardoso F., Buyse M., Braga S., Loi S., Harrison J. A., Bines J., Mook S., Decker N., Ravdin P., Therasse P., Rutgers E., van 't Veer L. J. and Piccart M. (20061024). Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. : Nature clinical practice. Oncology.

MLA

Bogaerts Jan, Cardoso Fatima, Buyse Marc, Braga Sofia, Loi Sherene, Harrison Jillian A, Bines Jacques, Mook Stella, Decker Nuria, Ravdin Peter, Therasse Patrick, Rutgers Emiel, van 't Veer Laura J and Piccart Martine. Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. : Nature clinical practice. Oncology. 20061024.